Performance Period: 4/15/2018 to 6/30/2019
The emergence of commercial gene therapy products will require a transition from bench-scale production of gene therapy vectors to manufacturing-scale operations. This project will develop a scalable platform process for production, purification, and analysis of adeno-associated virus (AAV) vectors used in gene therapy. This resource will be available for use throughout the NIIMBL network, and enable:
In addition to these broad project goals, the following specific objectives will be met:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
North Carolina State University